Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) PT at $8.63

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been assigned an average recommendation of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $8.63.

BIOX has been the topic of a number of recent research reports. Canaccord Genuity Group cut their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a report on Thursday, February 13th. Oppenheimer dropped their price objective on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 22nd. Finally, Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a report on Friday, February 7th.

Bioceres Crop Solutions Stock Down 4.3%

Shares of NASDAQ BIOX opened at $4.45 on Monday. The business has a 50-day moving average price of $4.35 and a 200 day moving average price of $5.50. The stock has a market cap of $279.06 million, a PE ratio of 222.61 and a beta of 0.40. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions has a 52-week low of $3.51 and a 52-week high of $11.86.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. Equities research analysts forecast that Bioceres Crop Solutions will post -0.05 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. JPMorgan Chase & Co. grew its position in Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after buying an additional 29,693 shares during the last quarter. Ping Capital Management Inc. lifted its stake in shares of Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after acquiring an additional 3,000 shares during the period. Fourth Sail Capital LP boosted its holdings in shares of Bioceres Crop Solutions by 16.6% in the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after acquiring an additional 527,859 shares in the last quarter. Ballast Asset Management LP boosted its holdings in shares of Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock valued at $2,620,000 after acquiring an additional 82,187 shares in the last quarter. Finally, Jump Financial LLC acquired a new position in shares of Bioceres Crop Solutions during the fourth quarter worth about $72,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.